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LETTERS
Underlying 
Medical Conditions 
and Hospitalization 
for Pandemic 
(H1N1) 2009, Japan
To the Editor: Early epidemio-
logic reports suggested that infection 
with pandemic (H1N1) 2009 virus 
most commonly occurred in teenag-
ers and young adults (1). Although 
this infection appears to have a mild 
clinical course and the mortality rate 
has been relatively low in Japan (1.6 
deaths/1 million population) (2), the 
reported number of patients with se-
vere (requiring intubation or admis-
sion to an intensive care unit) cases of 
this disease has been increasing (2). 
The difference in severity of pandemic 
(H1N1) 2009 infection may be attrib-
uted to differences in underlying med-
ical conditions or to age-related dif-
ferences in susceptibility. To explore 
these differences, we investigated the 
incidence of laboratory-conﬁ  rmed 
cases of pandemic (H1N1) 2009 virus 
infections resulting in hospitalization 
in Japan and the patients’ age-speciﬁ  c 
risks for hospitalization associated 
with underlying medical conditions.
During the outbreak in Japan, hos-
pitals, local public health centers, and 
local governments were required to 
report hospitalizations associated with 
pandemic (H1N1) 2009 virus to the 
Ministry of Health, Labour and Wel-
fare in Japan. Infection was conﬁ  rmed 
by PCR at local public health centers. 
The data for hospitalized patients were 
integrated through a nationwide sur-
veillance system, the interim National 
Epidemiologic Surveillance of Infec-
tious Diseases. 
We collected data on patients who 
were hospitalized in Japan for pandem-
ic (H1N1) 2009 virus infection from 
July 28 through December 14, 2009. 
The number of new cases (incidence) 
increased in the middle of August and 
peaked at the end of November (2). We 
excluded from analysis those patients 
who had been hospitalized for the pur-
pose of infection containment. Medical 
conditions were deﬁ  ned as diseases that 
are risk factors for severe illness asso-
ciated with seasonal inﬂ  uenza: chronic 
respiratory diseases, chronic cardiovas-
cular diseases, chronic renal diseases, 
chronic liver diseases, neurologic dis-
eases, hematologic diseases, diabetes, 
and immunosuppression caused by 
treatments or illnesses (including malig-
nant neoplasm) and chronic childhood 
diseases (3,4). Data on the prevalence 
of the diseases among the population 
were obtained from the 2005 National 
Patient Survey and from population 
estimates obtained by the Ministry of 
Internal Affairs and Communications 
in May 2009.
During the surveillance period, 
12,702 laboratory-conﬁ  rmed cases for 
which the patients required hospital-
ization were reported; 110 of these pa-
tients died (Table). Hospitalization in-
cidence was 10.0 admissions/100,000 
persons (overall incidence of hospi-
talization in the general population in 
2005 was 1,462.8 admissions/100,000 
persons). Median age of hospitalized 
patients was 7 years (interquartile 
range 5–11 years). Of the 10,721 
patients for whom type of care was 
known, 680 (6.4%) were admitted to 
an intensive care unit. Among 486 
hospitalized women 15–44 years of 
age, only 42 (8.6%) were pregnant; 
this percentage is small compared with 
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Table. Age-specific incidence and risk for hospitalization with laboratory-confirmed pandemic (H1N1) 2009 virus infection, Japan, July 
28–December 14, 2009* 
Patient 
characteristic 
Underlying medical conditions†  No underlying medical conditions‡ 
RR AR  No. (%) patients  Incidence/100,000§  No. (%) patients  Incidence/100,000§ 
Age, y             
    0–4  648 (22.1)  195.2  2,285 (77.9)  45.2  4.3  150.0 
    5–9  1,848 (32.6)  814.1  3,822 (67.4)  69.4  11.7  744.7 
    10–14  763 (35.2)  573.7  1,406 (64.8)  24.0  23.9  549.6 
    15–19  173 (38.9)  219.0  272 (61.1)  4.5  48.4  214.5 
    20–29  110 (43.8)  53.9  141 (56.2)  1.0  54.9  52.9 
    30–39  105 (49.8)  28.5  106 (50.2)  0.6  48.4  27.9 
    40–49  125 (61.6)  21.6  78 (38.4)  0.5  43.5  21.1 
    50–59  176 (76.9)  12.8  53 (23.1)  0.3  38.3  12.5 
  60–69  148 (77.5)  6.7  43 (22.5)  0.3  24.0  6.5 
    >70  324 (81.0)  8.2  76 (19.0)  0.5  17.9  7.8 
Gender¶            
    M  2,857 (35.3)  NA  5,236 (64.7)  NA     
    F  1,563 (33.9)  NA  3,046 (66.1)  NA     
*RR, relative risk for hospitalization; AR, attributable risk for hospitalization; NA, not available. Medical conditions defined as chronic respiratory diseases, 
chronic cardiovascular diseases, chronic renal diseases, chronic liver diseases, neurologic diseases, hematologic diseases, diabetes, and 
immunosuppression (including malignant neoplasm) and chronic childhood diseases.  
†n = 4,420 (43.8%); 83 patients died. 
‡n = 8,282 (65.2%); 27 patients died. 
§Incidence = no. case-patients with pandemic (H1N1) 2009 virus infection and a particular medical condition/total population having the same medical 
condition (e.g., population 0–4 years of age with medical condition).  
¶p value for difference in gender was 0.11, obtained by Ȥ
2 test (2-sided) for testing the null hypothesis. LETTERS
results of studies conducted in other 
countries (5–7). None of the pregnant 
women were in critical condition and 
none died of pandemic (H1N1) 2009 
infection during the surveillance pe-
riod. The overall lower prevalence of 
pregnant women in Japan (≈0.67% of 
the total population) compared with 
that in other countries (8) might ac-
count for the low number of pregnant 
women hospitalized for pandemic 
(H1N1) 2009 virus in Japan.
Of all 12,702 patients, 4,420 
(34.8%) had underlying medical condi-
tions. In terms of age, 1,848 (32.6%) of 
5,670 patients 5–9 years of age and 324 
(81.0%) of 400 patients >70 years of 
age had underlying medical conditions. 
For those with underlying medical con-
ditions, incidence of hospitalization 
was relatively higher for children than 
for adults; rates for hospitalized chil-
dren were 814.1, 573.7, and 219.0 per 
100,000 persons for those 5–9, 10–14, 
and 15–19 years of age, respectively; 
whereas, the rate for hospitalized adults 
60–69 years of age was 6.7/100,000 
persons. In all age categories, the inci-
dence of hospitalization for pandemic 
(H1N1) 2009 virus infection was nota-
bly higher for patients with underlying 
medical conditions than for those with-
out. The attributable risk for medical 
conditions associated with hospitaliza-
tion for pandemic (H1N1) 2009 virus 
infection was highest among patients 
5–9 and 10–14 years of age (744.7 and 
549.6, respectively), whereas the risk 
was lowest (6.5) among patients 60–69 
years of age. The relative risk associat-
ed with underlying medical conditions 
was comparatively higher for patients 
in age groups 15–19, 20–29, and 30–39 
years (48.4, 54.9, and 48.4, respec-
tively) than among those >70 years of 
age (17.9). In contrast to seasonal in-
ﬂ  uenza (4), persons <20 years of age 
had higher risk for hospitalization for 
pandemic (H1N1) 2009 than did older 
age groups. 
Considering our ﬁ  ndings regard-
ing the attributable risk for hospi-
talization, interventions that aim to 
control pandemic (H1N1) 2009 virus 
infection among children, especially 
those with underlying medical condi-
tions, can be considered key for mini-
mizing the strain (ﬁ  nancial, stafﬁ  ng, 
space) on the healthcare system. Our 
ﬁ  ndings justify prioritizing the treat-
ment of children and young adults by 
vaccination and early prescription of 
antiviral drugs.
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Internet Search 
Limitations and 
Pandemic Inﬂ  uenza, 
Singapore 
To the Editor: In the past few 
years, several publications have re-
ported that Internet search queries 
may usefully supplement other, tra-
ditional surveillance programs for 
infectious diseases (1–3). The phil-
anthropic arm of Google offers Flu 
Trends, a site that provides up-to-date 
estimates of inﬂ  uenza activity in 20 
countries of the Paciﬁ  c Rim and Eu-
rope (4) by using data mining tech-
niques to ﬁ  nd good predictors of his-
toric inﬂ  uenza indicators (1).
This service has yet to be extend-
ed to other countries and other diseases 
because access to ofﬁ  cial surveillance 
data is required, among other reasons. 
However, another Google service, In-
sights for Search, enables users to ﬁ  nd 
and download time-series data of rela-
tive counts of arbitrary searches for a 
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